Toxometris.ai

Check out the AI-related highlights of the German Pharm-Tox Summit (GPTS) 2024. ?? Our case study on the Toxometris-Risk-Score-Suite is coming soon!

An incredible week at Eurotox 2024, where in vitro and in silico solutions took center stage, proving their growing reliability and necessity in advancing safer drugs, environment, agro- and cosmetic chemicals. Image: Presentation at Eurotox 2024, sharing the results of the Tox24 challenge. Super proud that Toxometris.ai performed among the top 3 during the Tox24 challenge—our algorithms really shined!

Great news! We secured a shared second place, just 0.9% behind the first place, in the prestigious Tox24 challenge, organized by Horizon Europe, Chemical Research in Toxicology, and ICANN2024. This competition saw around 90 participants from across the globe competing to advance computational methods for predicting compounds' interference in biochemical pathways using only chemical structure data. An incredible validation of the AI capabilities and biological insights of Toxometris.AI. Congratulations to our perfect team and our partner BioCentric.AI! Your dedication is the key to our success. Let's keep up the great work! In collaboration with the Institute of Molecular Biology NAS RA #ComputationalBiology #AI #PredictiveToxicology

Excited to share that we will present our latest advancements in developmental toxicity prediction at Eurotox Congress 2024! We'll showcase how our cutting-edge AI-driven platform is pushing the boundaries of machine learning and toxicology allowing not only predict the outcome but also dives deep into the Molecular Initiating Events and Adverse Outcome Pathways of chemical-induced developmental toxicity. #Eurotox2024 #Toxicology #AI #DevelopmentalToxicity https://lnkd.in/dbc-P_Js

We're excited to share that our Chief Scientific Officer, Dr. Nelly Babayan, will give a talk at the webinar 'Enhancing Research: Integrating Toxometris.ai's In Silico Capabilities with eLabJournal.' She will discuss in silico capabilities, challenges, and solutions to improve the success rate of the drug development process. The integration of the Toxometris.ai platform with Eppendorf Group's eLabNext gives customers a seamless opportunity to perform ADMET property predictions directly from their digital lab platform. Don't miss out – register now! https://lnkd.in/ewpmfxYD